UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Carnegie Capital Asset Management LLC

Carnegie Capital Asset Management LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.4% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 12,863 shares of the healthcare conglomerate’s stock after selling 1,661 shares during the quarter. Carnegie Capital Asset Management LLC’s holdings in UnitedHealth Group were worth $5,151,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. GSA Capital Partners LLP acquired a new stake in UnitedHealth Group during the 4th quarter worth about $642,000. Rowland & Co. Investment Counsel ADV acquired a new stake in UnitedHealth Group during the 4th quarter worth about $169,000. Unigestion Holding SA boosted its position in UnitedHealth Group by 25.9% during the 4th quarter. Unigestion Holding SA now owns 4,786 shares of the healthcare conglomerate’s stock worth $2,403,000 after acquiring an additional 986 shares during the period. IHT Wealth Management LLC boosted its position in UnitedHealth Group by 9.9% during the 4th quarter. IHT Wealth Management LLC now owns 3,837 shares of the healthcare conglomerate’s stock worth $1,927,000 after acquiring an additional 345 shares during the period. Finally, Banco de Sabadell S.A boosted its position in UnitedHealth Group by 43.1% during the 4th quarter. Banco de Sabadell S.A now owns 10,402 shares of the healthcare conglomerate’s stock worth $5,235,000 after acquiring an additional 3,132 shares during the period. Institutional investors and hedge funds own 87.25% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $517.46 on Friday. UnitedHealth Group Incorporated has a 12 month low of $383.12 and a 12 month high of $553.29. The company has a market cap of $484.02 billion, a P/E ratio of 27.02, a P/E/G ratio of 1.61 and a beta of 0.76. The business’s 50 day moving average is $530.11 and its two-hundred day moving average is $512.45. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.60.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The company had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. During the same quarter last year, the firm earned $4.70 EPS. UnitedHealth Group’s revenue for the quarter was up 12.6% compared to the same quarter last year. On average, equities analysts expect that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 20th. Stockholders of record on Monday, September 12th were issued a dividend of $1.65 per share. This represents a $6.60 annualized dividend and a dividend yield of 1.28%. The ex-dividend date was Friday, September 9th. UnitedHealth Group’s payout ratio is presently 34.46%.

Insider Activity at UnitedHealth Group

In related news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a legal filing with the SEC, which is available through this link. In related news, CEO Andrew Witty sold 11,376 shares of the business’s stock in a transaction on Monday, July 18th. The stock was sold at an average price of $527.90, for a total value of $6,005,390.40. Following the sale, the chief executive officer now owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Stephen J. Hemsley sold 99,312 shares of the business’s stock in a transaction on Tuesday, July 26th. The shares were sold at an average price of $534.27, for a total value of $53,059,422.24. Following the completion of the sale, the director now directly owns 787,372 shares in the company, valued at approximately $420,669,238.44. The disclosure for this sale can be found here. Insiders have sold a total of 139,051 shares of company stock valued at $74,450,958 in the last 90 days. 0.40% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the company. Argus raised their price target on UnitedHealth Group from $580.00 to $650.00 and gave the stock a “buy” rating in a research note on Monday, July 25th. BMO Capital Markets raised their price target on UnitedHealth Group from $600.00 to $610.00 in a research note on Wednesday, July 20th. SVB Leerink raised their price target on UnitedHealth Group from $600.00 to $625.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Loop Capital started coverage on UnitedHealth Group in a research note on Thursday, June 16th. They set a “buy” rating and a $575.00 price target for the company. Finally, Morgan Stanley raised their price objective on UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $586.40.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.